August 19, 2017 7:58 PM ET

Biotechnology

Company Overview of Regenxbio Inc.

Executive Profile

Allan M. Fox

Director, Regenxbio Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
69$135,563

Background

Mr. Allan M. Fox has been a Partner of FoxKiser since 1986. Mr. Fox is the Founder of FoxKiser. He is specializing in identifying and enhancing business opportunities and improving competitive market position in the pharmaceutical and biotechnology industries. Before forming FOXKISER twenty-five years ago, Mr. Fox established the Washington office of the law firm of Kaye, Scholer, Fierman, Hays & Handler. Mr. Fox has been a Director of REGENX Biosciences, LLC (now ...

Corporate Headquarters

9600 Blackwell Road
Rockville, Maryland 20850

United States

Phone: 240-552-8181
Fax: --

Board Members Memberships

2009-Present
Director

Education

JD
Temple University
BA
Temple University
Master's Degree
Yale Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$35,000
Total Calculated Compensation$135,563
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Alexander D. Macrae M.B., Ch.B, Ph.D., MRCPCEO, President & Director
Sangamo Therapeutics, Inc.
$697.0K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Regenxbio Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.